...® line of Surgical Microscope Accessories incl...ctive lenses, fiber optic cables, and fiberoptic r...rgical Video Adaptor (US pat. no. 5,264,928) is th...hip and 3CCD cameras on the same adaptor body. It ...
Inquire
Inquire
...WaveFront System is an ophthalmic diagnostic instr...ront aberrations of the human eye using a Hartmann...sed to determine regular (sphero-cylindrical) refr...t cause decreased or blurry vision in the human ey...
Medicine Products:(Date:12/2/2008)...ire-USNewswire/ -- Today, advocates for teen,dati...coming together at Liz,Claiborne Inc. to launch ,...,Dating Abuse. Ann and Chris Burke, educators and ...her abusive ex-boyfriend, are joining efforts with...national coalition that will,consist of parents, ...
(Date:12/2/2008)...ewswire-FirstCall/ -- UnitedHealth Group,(NYSE: ...nity to become "health,care heroes" by learning a...ress it and implementing the programs in their com...e-learning, health literacy initiative,designed t...s and youth,leaders, to create and implement loca...
(Date:12/2/2008)...having the procedure, study says , , TUE...ost common form of epilepsy who don,t respond to d...atically improved quality of life at that, if they...the finding of a new study that relied on computer... temporal lobe region for people with temporal lob...
(Date:12/2/2008)... a day linked to atrial fibrillation, study finds... A healthy middle-aged woman can have up to two dr...rmal heartbeat called atrial fibrillation, a new s.... Albert, a professor of medicine at Harvard Medic...,s Health study, looking for a relationship betwee...
Breaking Medicine News(10 mins):Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3Health News:Light Drinking Poses No Heart Risk for Women 2(Date:12/2/2008)...alif., Dec. 2 TorreyPines Therapeu...ive results from a 26 patient Phase II trial evalu...ostomia, or dry mouth, in patients with Sjogren,s ...atistically significant increase in salivary flow ... 10 mg, 15 mg, and 20 mg. These doses were safe an...
(Date:12/1/2008)...Md., Dec. 1 Vanda Pharma...on in The Lancet , one of the world,s leading med...ovel circadian regulator, experimental compound ta...m et al(1) is entitled "Melatonin agonist tasimelt...ime shift: two randomised controlled multicentre t...
(Date:12/1/2008)...udy shows the Prox1 gene is a two-way switch that,... to be reprogrammed so that they lose their identi... , MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNews...ch Hospital have discovered that a certain differe...ty that it requires the constant expression of a g...
(Date:12/1/2008)...c. 1 GeoVax Labs, Inc.,...chnology company developing,human vaccines for di...us) and,other infectious agents, announced today ...als will take place in twelve sites across North a...ollaboration with The National Institutes of,Heal...
Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Court Throws Out Restraining Order Against SEIU 17506 1Court Throws Out Restraining Order Against SEIU 17506 2Court Throws Out Restraining Order Against SEIU 17506 3JCI table of contents 3A April 22 2008 4792 1JCI table of contents 3A April 22 2008 4792 2JCI table of contents 3A April 22 2008 4792 3JCI table of contents 3A April 22 2008 4792 4JCI table of contents 3A April 22 2008 4792 5JCI table of contents 3A April 22 2008 4792 6JCI table of contents 3A April 22 2008 4792 7JCI table of contents 3A April 22 2008 4792 8JCI table of contents 3A April 22 2008 4792 9JCI table of contents 3A April 22 2008 4792 10JCI table of contents 3A April 22 2008 4792 11JCI table of contents 3A April 22 2008 4792 12Why fruit eating bats eat dirt 3005 1Why fruit eating bats eat dirt 3005 2CNA NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike 17503 1CNA NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike 17503 2...stCall/ --,EntreMed, Inc. , a clinical-stage pharm...treatment of cancer and inflammatory diseases,ann... its Aurora,kinase - angiogenesis inhibitor, ENMD-...ster presentations by EntreMed,scientists at the 2...ing held May 31 - June 1, 2007 in Boston, Massachu...
...e but Devastating,Condition , LONDON, June 1, 2007...he University of Leicester and have today (Friday ...treatment of a rare but,devastating medical condit...n a world first, the clinicians and scientists fro...tient with promising,results. Their preliminary da...
Other Medicine Technology:EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models 2EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5